The smallpox antiviral drug tecovirimat, developed in the United States, has proven to be a viable drug to combat monkey disease, the journal reported. lancet.
“While our colleagues are trying to unravel the roots of this monkeypox epidemic and how it spreads, we are interested in what antiviral drugs may have been used to combat this disease in the past,” said university researcher Hugh Adler. Liverpool in England.
Based on the results of the analysis of data from 2018 to 2021, he announced the identification of two main drugs – brincidofovir and tecovirimat. The first drug was created to combat chickenpox, and the second was created in the United States in accordance with the government’s program to combat the threat of biological weapons.
While Tecovirimat could suppress the replication of the human smallpox virus, brincidofovir was not that effective. The scientists hope that the less dangerous monkeypox will also be affected by tecovirimate.
Formerly MD announcedWhy is the monkeypox vaccine not needed?
Source: Gazeta
